5 results on '"Esther Tomkins"'
Search Results
2. Migraine and Headache Care in the Republic of Ireland: History and a Vision for the Future Influenced by the COVID‐19 Pandemic
- Author
-
Martin Ruttledge, Audrey Craven, and Esther Tomkins
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,business.industry ,Migraine Disorders ,Headache ,Clinical Neurology ,COVID-19 ,Primary care ,medicine.disease ,The Republic ,Public healthcare ,Neurology ,Migraine ,Multidisciplinary approach ,Family medicine ,Health care ,Pandemic ,medicine ,Humans ,Neurology (clinical) ,business ,Ireland - Abstract
Background The care and management of migraine/headache patients in the Republic of Ireland over the last 25 years are summarized in this article. Methods Collaboration between voluntary patient organizations (the Migraine Association of Ireland or MAI), primary care services, and hospital/community shared healthcare professionals (most notably the headache specialist nurse), is highlighted as one of the key features of this management strategy in an underfunded and under-resourced public healthcare system. Conclusion The migraine/headache community in Ireland is small, but they have been dedicated in their commitment to improving care for their patients for more than 2 decades. As a result, they have been successful in recent years, both nationally and internationally, in terms of financial funding and support for their multidisciplinary and collaborative approach.
- Published
- 2020
- Full Text
- View/download PDF
3. Central 5-Ht Receptor Hypersensitivity in Migraine Without Aura
- Author
-
Timothy G. Dinan, Eugene M Cassidy, Veronica O'Keane, Orla Hardiman, and Esther Tomkins
- Subjects
Adult ,Migraine without Aura ,Agonist ,Serotonin ,medicine.medical_specialty ,Aura ,medicine.drug_class ,media_common.quotation_subject ,Analgesic ,Administration, Oral ,Buspirone ,Reference Values ,Internal medicine ,Humans ,Medicine ,5-HT receptor ,Menstrual cycle ,media_common ,business.industry ,General Medicine ,Middle Aged ,medicine.disease ,Prolactin ,Serotonin Receptor Agonists ,Endocrinology ,Migraine ,Receptors, Serotonin ,Female ,Neurology (clinical) ,business ,Receptors, Serotonin, 5-HT1 ,medicine.drug - Abstract
Serotonin has long been implicated as a key neurotransmitter in migraine. There is a dearth of research specifically examining 5-HT1A receptor sensitivity in migraine despite the importance of this receptor in regulating central serotonergic tone. In this study we examined the hypothesis that migraine without aura is associated with hypersensitivity of central 5-HT1A receptors, using a 5-HT1A neuroendocrine challenge drug and comparing serum prolactin responses between a test group with migraine and a matched group of healthy controls. Twelve female subjects fulfilling International Headache Society (IHS) criteria for migraine without aura were evaluated. Following an overnight fast, subjects presented for testing at 9am. An intravenous canula was inserted and serum prolactin was assessed at baseline and every 30 min for 3 h following a single dose of 30 mg oral buspirone, a 5-HT1A-receptor agonist. Subjects were assessed during the first 5 days of the menstrual cycle. No subjects were taking psychotropic medication or migraine prophylactic treatment. Patients with current or previous psychiatric disorder, daily headache or analgesic overuse were excluded. 16 healthy female volunteers matched for age and menstrual status were also evaluated and served as controls. There was no difference in baseline prolactin between groups. There was a significant rise in prolactin following buspirone in both groups. Subjects with migraine had a significantly increased prolactin response to buspirone (delta max) compared to controls ( P < 0.001). This study supports the hypothesis that migraine without aura is associated with a relative hypersensitivity of central 5-HT1A receptors. This is of relevance given the role of the 5-HT1A receptor in controlling raphe 5-HT tone and in the possible association between migraine and anxiety and depression.
- Published
- 2003
- Full Text
- View/download PDF
4. Factors associated with burden of primary headache in a specialty clinic
- Author
-
Veronica O'Keane, Esther Tomkins, Eugene M. Cassidy, and Orla Hardiman
- Subjects
Adult ,Male ,medicine.medical_specialty ,Tension headache ,Adolescent ,Migraine Disorders ,Disability Evaluation ,Chronic Migraine ,Cost of Illness ,Recurrence ,Medicine ,Outpatient clinic ,Humans ,Psychiatry ,Depression (differential diagnoses) ,Aged ,business.industry ,Depression ,Tension-Type Headache ,Beck Depression Inventory ,Middle Aged ,medicine.disease ,Neurology ,Migraine ,Chronic Disease ,Physical therapy ,Pain Clinics ,Female ,Neurology (clinical) ,General Health Questionnaire ,business ,Psychopathology - Abstract
Objective.—To examine factors associated with social, occupational, and psychological burden of common primary headache (migraine and tension-type headache). Background.—The personal and social burden of primary headache is high. Health, occupational, social, and psychological factors contributing to burden in people with disabling headache have not been fully unravelled. Methods.—One hundred eighty consecutive patients with either migraine or tension-type headache attending a specialty headache outpatient clinic for the first time were evaluated over a 9-month period. Headache subtype was operationally defined according to International Headache Society criteria. Headache frequency, duration, and severity were recorded. Occupational and social disability were quantified using the Migraine Disability Assessment questionnaire. Psychological burden was quantified using the 28-item General Health Questionnaire, the Beck Depression Inventory, and the State-Trait Anxiety Inventory. Premorbid vulnerability to life stress was quantified using the neuroticism subscale of the Eysenck Personality Inventory. Results.—Patients with frequent (chronic) headache scored higher on the Migraine Disability Assessment questionnaire and had higher Beck Depression Inventory and General Health Questionnaire depression scores than those with less frequent (episodic) headache. Frequency of headache, but not pain severity, duration, or diagnosis, predicted both Migraine Disability Assessment total disability and General Health Questionnaire/Beck Depression Inventory depression. Neuroticism was predictive of depression but not disability. Patients with chronic migraine had the highest depression and disability scores. Conclusion.—The number of days per month with headache is a key determinant of headache-related burden in those attending specialty clinics. Frequent (chronic) headache is associated with significantly higher psychopathology scores and general social impairment, but the direction of this relationship is not clear. Those with migraine and chronicity are the most impaired.
- Published
- 2003
5. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone
- Author
-
Eugene M Cassidy, Orla Hardiman, Veronica O'Keane, Timothy G. Dinan, Neda Sharifi, and Esther Tomkins
- Subjects
Agonist ,Adult ,medicine.medical_specialty ,Time Factors ,Hydrocortisone ,Aura ,medicine.drug_class ,Migraine Disorders ,Buspirone ,Internal medicine ,medicine ,Humans ,5-HT receptor ,Menstrual Cycle ,Analysis of Variance ,Estradiol ,Middle Aged ,medicine.disease ,Neurosecretory Systems ,Migraine with aura ,Prolactin ,Serotonin Receptor Agonists ,Anesthesiology and Pain Medicine ,Endocrinology ,Neurology ,Migraine ,Dopamine receptor ,Receptors, Serotonin ,Female ,Neurology (clinical) ,medicine.symptom ,Psychology ,Receptors, Serotonin, 5-HT1 ,medicine.drug - Abstract
Despite the importance of the 5HT1A receptor in regulating central serotonergic tone, there is a dearth of research examining its role in migraine. In this study, we examined the hypothesis that there would be altered neuroendocrine responses to a 5HT1A agonist challenge in different migraine subtypes. Prolactin (PRL) responses to the 5HT1A receptor agonist drug buspirone were compared in 30 female subjects with migraine (ten migraine with aura, MA; ten migraine without aura, MO and ten chronic/transformed migraine, CM), and ten healthy controls matched for age, gender and menstrual status. None of the subjects were taking psychotropic medication or migraine prophylactic treatment and those with formal psychiatric disorder were excluded. Endocrine responses were determined by measuring differences between baseline PRL and maximum increases post-buspirone (deltaPRL). There was no difference in baseline PRL between groups. MA subjects did not differ in their PRL responses to buspirone compared to healthy controls. The MO group had a four-fold increase in mean deltaPRL responses compared to healthy controls. Mean deltaPRL was also increased in the CM group compared to controls, but the difference was less exaggerated. This study indicates that there is supersensitive central amine receptor function in MO and CM, but not in MA. These findings support the hypothesis that central 5HT function differs among the migraine subtypes. The results also suggest that migrainous 'transformation' may be associated with adaptive changes in central 5HT receptor sensitivity. The relative contribution of 'state' and 'trait' receptor function to these findings as well as the possible role of dopamine receptors is discussed.
- Published
- 2003
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.